The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001923:Brain Chemistry; D003042:Cocaine / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D006213:Hallucinogens / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D008635:Mescaline / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism*; D011562:Psilocybin / Q000494:pharmacology*; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology*
D000227:Adenine Nucleotides; D006213:Hallucinogens; D010710:Phosphates; D010725:Phosphocreatine; D011562:Psilocybin; D004295:Dihydroxyphenylalanine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D006916:5-Hydroxytryptophan; D012601:Scopolamine; D003042:Cocaine; D008635:Mescaline